Literature DB >> 12384545

Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice.

Priscilla P L Chiu1, Evgueni Ivakine, Steven Mortin-Toth, Jayne S Danska.   

Abstract

Transformed lymphocytes exhibit aberrant growth potential resulting from enhanced proliferation and resistance to apoptotic stimuli. These mechanisms also influence the development of autoimmune disease, where dysregulated lymphocyte homeostasis has been implicated in expansion of autoreactive T cells. In the nonobese diabetic (NOD) mouse, a murine model of autoimmune type 1 diabetes and Sjögren's syndrome, T cells are apoptosis resistant compared with other mouse strains, a feature thought to potentiate their autoimmune function. NOD mice congenic for the severe combined immunodeficiency scid mutation (NOD.scid) have an incidence of pro-T-cell lymphoma far in excess of scid mutants on other genetic backgrounds. This mutation arrests lymphocyte development secondary to a generalized defect in double-strand DNA break repair that compromises V(D)J recombination. To distinguish between the contributions of immunodeficiency and defective double-strand DNA break repair to lymphoma susceptibility on the NOD background, we examined the incidence, phenotype, and molecular mechanisms of lymphoma development in two immunodeficient NOD strains with normal DNA repair function. We report that NOD mice deficient in mature B cells (NOD. micro MT) or mature T and B cells (NOD.RAG-2(-/-)) display a high incidence of lymphoma of both T- and B-cell origin compared with these mutations on other genetic backgrounds. Strikingly, the lymphoma incidence in both strains was greater in females, mirroring the greater incidence of autoimmune type 1 diabetes in NOD females than in males. The high incidence of autoimmune diabetes and lymphoma in immunodeficiency NOD mice suggests the presence of genetic modifiers that affect lymphocyte homeostasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384545

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Interleukin-15 deficiency promotes the development of T-cell acute lymphoblastic leukemia in non-obese diabetes mice with severe combined immunodeficiency.

Authors:  D Bobbala; R Kandhi; X Chen; M Mayhue; E Bouchard; J Yan; H Knecht; F Barabé; S Ramanathan; S Ilangumaran
Journal:  Leukemia       Date:  2016-02-15       Impact factor: 11.528

2.  Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

Authors:  Paolo Fiorina; Mollie Jurewicz; Andrea Augello; Andrea Vergani; Shirine Dada; Stefano La Rosa; Martin Selig; Jonathan Godwin; Kenneth Law; Claudia Placidi; R Neal Smith; Carlo Capella; Scott Rodig; Chaker N Adra; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

3.  Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.

Authors:  Zheng Chen; Paul Ayala; Michael Wang; Luis Fayad; Ruth L Katz; Jorge Romaguera; Nancy Caraway; Sattva S Neelapu; Larry W Kwak; Paul J Simmons; Nami McCarty
Journal:  Stem Cell Res       Date:  2010-08-06       Impact factor: 2.020

4.  Loss of T cell progenitor checkpoint control underlies leukemia initiation in Rag1-deficient nonobese diabetic mice.

Authors:  Mary A Yui; Ni Feng; Jingli A Zhang; Chen Yee Liaw; Ellen V Rothenberg; Jeffrey A Longmate
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

5.  Cutting edge: genetic characterization of IFN-producing killer dendritic cells.

Authors:  Fanny Guimont-Desrochers; Zachary John Cappello; Miguel Chagnon; Marcia McDuffie; Sylvie Lesage
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.

Authors:  William Matsui; Qiuju Wang; James P Barber; Sarah Brennan; B Douglas Smith; Ivan Borrello; Ian McNiece; Lan Lin; Richard F Ambinder; Craig Peacock; D Neil Watkins; Carol Ann Huff; Richard J Jones
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

7.  In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

Authors:  Gerhard Bauer; Mo A Dao; Scott S Case; Todd Meyerrose; Louisa Wirthlin; Ping Zhou; Xiuli Wang; Phillip Herrbrich; Jesusa Arevalo; Susie Csik; Dianne C Skelton; Jon Walker; Karen Pepper; Donald B Kohn; Jan A Nolta
Journal:  Mol Ther       Date:  2008-05-06       Impact factor: 11.454

8.  Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma/Leukemia in NSG Mice.

Authors:  Heather Tillman; Laura J Janke; Amy Funk; Peter Vogel; Jerold E Rehg
Journal:  Vet Pathol       Date:  2019-11-18       Impact factor: 2.221

9.  Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect.

Authors:  Xingmin Wang; Yonghong Yang; Mark M Huycke
Journal:  Gut       Date:  2014-06-06       Impact factor: 23.059

10.  Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research.

Authors:  Magdalena Cybula; Lin Wang; Luyao Wang; Ana Luiza Drumond-Bock; Katherine M Moxley; Doris M Benbrook; Camille Gunderson-Jackson; Maria J Ruiz-Echevarria; Resham Bhattacharya; Priyabrata Mukherjee; Magdalena Bieniasz
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.